Evidence map›Paper›PMID 37163372›Full record

ArticleCell reports2023

Acetyl-CoA carboxylase 1 is a suppressor of the adipocyte thermogenic program.

Adilson Guilherme, Leslie A Rowland, Nicole Wetoska, Emmanouela Tsagkaraki, Kaltinaitis B Santos, Alexander H Bedard, Felipe Henriques, Mark Kelly, Sean Munroe, David J Pedersen and 9 more

Open access · goldAbstract read
In one paragraph

Article in Cell reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
4.9field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 28 citations in OpenAlex.

  1. Animals : an open access journal from MDPI · 2026
    Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Acetate Administration Ameliorates Streptozotocin-Induced Hyperglycemia and Adipose Tissue Loss.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2025
    Article
  11. Article
  12. Tissue specific roles of fatty acid oxidation.Advances in biological regulation · 2025
    Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 3 institutions in 1 country.

Adilson GuilhermeProgram in Molecular Medicine, University of Massachusetts Chan Medical School, Worcester, MA 01605, USA. Electronic address: adilson.guilherme@umassmed.edu.
Leslie A RowlandProgram in Molecular Medicine, University of Massachusetts Chan Medical School, Worcester, MA 01605, USA.
Nicole WetoskaProgram in Molecular Medicine, University of Massachusetts Chan Medical School, Worcester, MA 01605, USA.
Emmanouela TsagkarakiProgram in Molecular Medicine, University of Massachusetts Chan Medical School, Worcester, MA 01605, USA.
Kaltinaitis B SantosProgram in Molecular Medicine, University of Massachusetts Chan Medical School, Worcester, MA 01605, USA.
Alexander H BedardProgram in Molecular Medicine, University of Massachusetts Chan Medical School, Worcester, MA 01605, USA.
Felipe HenriquesProgram in Molecular Medicine, University of Massachusetts Chan Medical School, Worcester, MA 01605, USA.
Mark KellyProgram in Molecular Medicine, University of Massachusetts Chan Medical School, Worcester, MA 01605, USA.
Sean MunroeProgram in Molecular Medicine, University of Massachusetts Chan Medical School, Worcester, MA 01605, USA.
David J PedersenProgram in Molecular Medicine, University of Massachusetts Chan Medical School, Worcester, MA 01605, USA.
Olga R IlkayevaDuke Molecular Physiology Institute and Sarah W. Stedman Nutrition and Metabolism Center, Duke University School of Medicine, Durham, NC 27701, USA; Department of Medicine, Duke University School of Medicine, Durham, NC 27705, USA.
Timothy R KovesDuke Molecular Physiology Institute and Sarah W. Stedman Nutrition and Metabolism Center, Duke University School of Medicine, Durham, NC 27701, USA; Department of Medicine, Duke University School of Medicine, Durham, NC 27705, USA.
Lauren TauerProgram in Molecular Medicine, University of Massachusetts Chan Medical School, Worcester, MA 01605, USA.
Meixia PanBarshop Institute for Longevity and Aging Studies, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229, USA.
Xianlin HanBarshop Institute for Longevity and Aging Studies, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229, USA; Department of Medicine, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229, USA.
Jason K KimProgram in Molecular Medicine, University of Massachusetts Chan Medical School, Worcester, MA 01605, USA; Division of Endocrinology, Metabolism, and Diabetes, Department of Medicine, University of Massachusetts Chan Medical School, Worcester, MA 01605, USA.
Christopher B NewgardDuke Molecular Physiology Institute and Sarah W. Stedman Nutrition and Metabolism Center, Duke University School of Medicine, Durham, NC 27701, USA; Department of Medicine, Duke University School of Medicine, Durham, NC 27705, USA; Departments of Pharmacology and Cancer Biology, Duke University School of Medicine, Durham, NC 27705, USA.
Deborah M MuoioDuke Molecular Physiology Institute and Sarah W. Stedman Nutrition and Metabolism Center, Duke University School of Medicine, Durham, NC 27701, USA; Department of Medicine, Duke University School of Medicine, Durham, NC 27705, USA; Departments of Pharmacology and Cancer Biology, Duke University School of Medicine, Durham, NC 27705, USA.
Michael P CzechProgram in Molecular Medicine, University of Massachusetts Chan Medical School, Worcester, MA 01605, USA. Electronic address: michael.czech@umassmed.edu.
University of Massachusetts Chan Medical School · USDuke University · USThe University of Texas Health Science Center at San Antonio · US

Funding

TRANSGENIC COREP30AG013319 · NIA · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI JAMES FLOYD NELSON · 1995 to 2026
$30.6M
Pilot & Feasibility ProgramP30DK124723 · NIDDK · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI P Darrell Neufer · 2020 to 2026
$11.0M
Role of Carnitine Acetyltransferase in Mitochondrial and Metabolic FunctionR01DK089312 · NIDDK · DUKE UNIVERSITY · PI DEBORAH M MUOIO · 2010 to 2026
$7.8M
Insulin Signaling and Metabolic Regulation in AdipocytesR37DK030898 · NIDDK · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI CZECH, MICHAEL P · 1996 to 2021
$7.2M
Paracrine Signaling by Kupffer Cells in Hepatic Insulin ResistanceR01DK103047 · NIDDK · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI CZECH, MICHAEL P · 2015 to 2023
$5.0M
UMass Mouse Metabolic Phenotyping Center - Metabolism CoreU2CDK093000 · NIDDK · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI KIM, JASON K · 2016 to 2021
$4.6M
Adipocyte to neuron signaling in thermogenic programming of white adipose tissueR01DK116056 · NIDDK · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI CZECH, MICHAEL P · 2019 to 2023
$2.9M
Mechanisms connecting dysregulated BCAA, glucose & lipid metabolism in the pathogenesis of metabolic diseaseR01DK121710 · NIDDK · DUKE UNIVERSITY · PI HERMAN, MARK A, NEWGARD, CHRISTOPHER B · 2019 to 2022
$2.7M
Insulin Signaling and Metabolic Regulation in AdipocytesR01DK030898 · NIDDK · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI CZECH, MICHAEL P · 1986 to 2011
$2.7M
UMass Mouse Metabolic Phenotyping CenterU24DK093000 · NIDDK · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI KIM, JASON K · 2011 to 2015
$2.1M
Role of Interferon-Gamma / Interleukin-12 Axis in Metabolic Liver DiseaseR01DK133772 · NIDDK · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI JASON K KIM · 2023 to 2026
$1.9M
NIA NIH HHS P30 AG013319NIDDK NIH HHS P30 DK124723NIDDK NIH HHS R01 DK030898NIDDK NIH HHS R01 DK089312NIDDK NIH HHS R01 DK103047NIDDK NIH HHS R01 DK116056NIDDK NIH HHS R01 DK121710NIDDK NIH HHS R01 DK133772NIDDK NIH HHS R37 DK030898NIDDK NIH HHS U24 DK093000NIDDK NIH HHS U2C DK093000
6 · The paper itself

Abstract

Disruption of adipocyte de novo lipogenesis (DNL) by deletion of fatty acid synthase (FASN) in mice induces browning in inguinal white adipose tissue (iWAT). However, adipocyte FASN knockout (KO) increases acetyl-coenzyme A (CoA) and malonyl-CoA in addition to depletion of palmitate. We explore which of these metabolite changes triggers adipose browning by generating eight adipose-selective KO mouse models with loss of ATP-citrate lyase (ACLY), acetyl-CoA carboxylase 1 (ACC1), ACC2, malonyl-CoA decarboxylase (MCD) or FASN, or dual KOs ACLY/FASN, ACC1/FASN, and ACC2/FASN. Preventing elevation of acetyl-CoA and malonyl-CoA by depletion of adipocyte ACLY or ACC1 in combination with FASN KO does not block the browning of iWAT. Conversely, elevating malonyl-CoA levels in MCD KO mice does not induce browning. Strikingly, adipose ACC1 KO induces a strong iWAT thermogenic response similar to FASN KO while also blocking malonyl-CoA and palmitate synthesis. Thus, ACC1 and FASN are strong suppressors of adipocyte thermogenesis through promoting lipid synthesis rather than modulating the DNL intermediates acetyl-CoA or malonyl-CoA.

Indexed as

Acetyl-CoA CarboxylaseAdipocytesAcetyl Coenzyme AAnimalsFatty Acid SynthasesMiceMice, KnockoutPalmitatesThermogenesisAcetyl-CoA CarboxylaseAcetyl Coenzyme AFatty Acid SynthasesPalmitatesACC1acetyl-CoAadipose tissuebrowningCP: MetabolismFASNfatty acidslipogenesismalonyl-CoAthermogenesisUCP1

Identifiers

PMID37163372
PMCPMC10286105
OpenAlexW4376132803

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.